Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
6.58
-0.19 (-2.81%)
Jul 10, 2026, 2:08 PM EDT - Market open
Aligos Therapeutics Market Cap
Aligos Therapeutics has a market cap or net worth of $40.72 million as of July 10, 2026. Its market cap has decreased by -19.19% in one year.
Market Cap
40.72M
Enterprise Value
-8.66M
1-Year Change
-19.19%
Ranking
Category
Stock Price
$6.58
Market Cap Chart
Since the IPO on October 16, 2020, Aligos Therapeutics's market cap has decreased from $553.35M to $40.72M, a decrease of -92.64%. That is a compound annual growth rate of -36.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 40.72M | -29.00% |
| Dec 31, 2025 | 57.35M | -61.21% |
| Dec 31, 2024 | 147.87M | 197.20% |
| Dec 29, 2023 | 49.75M | 21.95% |
| Dec 30, 2022 | 40.80M | -91.93% |
| Dec 31, 2021 | 505.85M | -52.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eloxx Pharmaceuticals | 45.73M |
| PDS Biotechnology | 44.75M |
| Tvardi Therapeutics | 44.09M |
| Hyperion DeFi | 43.65M |
| Veru Inc. | 43.26M |
| Apollomics | 41.66M |
| RenovoRx | 40.40M |
| Grace Therapeutics | 40.32M |